INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 202 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $606,258 | +40.0% | 32,700 | +213.2% | 0.00% | 0.0% |
Q3 2020 | $433,000 | +83.5% | 10,441 | +112.0% | 0.00% | – |
Q2 2020 | $236,000 | -51.4% | 4,925 | -36.2% | 0.00% | -100.0% |
Q1 2020 | $486,000 | -74.1% | 7,724 | -49.1% | 0.00% | -50.0% |
Q4 2019 | $1,879,000 | +94.5% | 15,165 | +3.6% | 0.00% | +100.0% |
Q3 2019 | $966,000 | -17.0% | 14,640 | +0.1% | 0.00% | 0.0% |
Q2 2019 | $1,164,000 | -8.6% | 14,631 | +28.4% | 0.00% | 0.0% |
Q1 2019 | $1,274,000 | +53.7% | 11,391 | +35.3% | 0.00% | 0.0% |
Q4 2018 | $829,000 | -28.5% | 8,418 | -8.2% | 0.00% | 0.0% |
Q3 2018 | $1,159,000 | +76.9% | 9,169 | +17.6% | 0.00% | 0.0% |
Q2 2018 | $655,000 | +36.5% | 7,800 | 0.0% | 0.00% | – |
Q1 2018 | $480,000 | +5.3% | 7,800 | 0.0% | 0.00% | – |
Q4 2017 | $456,000 | +57.2% | 7,800 | +56.0% | 0.00% | – |
Q3 2017 | $290,000 | -69.6% | 5,000 | -35.7% | 0.00% | -100.0% |
Q2 2017 | $953,000 | +7.2% | 7,772 | -1.3% | 0.00% | 0.0% |
Q1 2017 | $889,000 | +7.8% | 7,872 | +3.6% | 0.00% | 0.0% |
Q4 2016 | $825,000 | -47.5% | 7,595 | -22.2% | 0.00% | -50.0% |
Q3 2016 | $1,571,000 | +30.0% | 9,759 | +15.3% | 0.00% | +100.0% |
Q2 2016 | $1,208,000 | -22.9% | 8,465 | -30.6% | 0.00% | -50.0% |
Q1 2016 | $1,566,000 | -13.2% | 12,195 | +1.2% | 0.00% | 0.0% |
Q4 2015 | $1,805,000 | -60.9% | 12,045 | -56.8% | 0.00% | -66.7% |
Q3 2015 | $4,621,000 | -28.6% | 27,860 | +4.0% | 0.01% | -14.3% |
Q2 2015 | $6,469,000 | -46.5% | 26,800 | -37.5% | 0.01% | -50.0% |
Q1 2015 | $12,085,000 | +80.6% | 42,855 | -0.1% | 0.01% | +100.0% |
Q4 2014 | $6,690,000 | -2.1% | 42,885 | +48.6% | 0.01% | -12.5% |
Q3 2014 | $6,831,000 | +132.0% | 28,860 | +131.9% | 0.01% | +100.0% |
Q2 2014 | $2,945,000 | -43.1% | 12,445 | -20.7% | 0.00% | -33.3% |
Q1 2014 | $5,178,000 | – | 15,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |